Literature DB >> 29114465

Advance in predictive and prognostic marker assessments in lung cancer.

Mari Mino-Kenudson1.   

Abstract

Entities:  

Year:  2017        PMID： 29114465      PMCID： PMC5653526          DOI： 10.21037/tlcr.2017.08.04

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  4 in total

1.  Genotyping lung cancer is an investment in the future.

Authors:  Christopher G Azzoli; Jeffrey Engelman; Panos Fidias; Justin F Gainor; Rebecca S Heist; Elizabeth B Lamont; Inga T Lennes; Rachel P Rosovsky; Lecia V Sequist; Alice Tsang Shaw; Jennifer S Temel
Journal:  J Clin Oncol       Date:  2014-09-08       Impact factor: 44.544

2.  Clinical course of stage IV invasive mucinous adenocarcinoma of the lung.

Authors:  Yoon Jin Cha; Hye Ryun Kim; Hye-Jeong Lee; Byoung Chul Cho; Hyo Sup Shim
Journal:  Lung Cancer       Date:  2016-11-06       Impact factor: 5.705

3.  The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer.

Authors:  Kari Chansky; Frank C Detterbeck; Andrew G Nicholson; Valerie W Rusch; Eric Vallières; Patti Groome; Catherine Kennedy; Mark Krasnik; Michael Peake; Lynn Shemanski; Vanessa Bolejack; John J Crowley; Hisao Asamura; Ramón Rami-Porta
Journal:  J Thorac Oncol       Date:  2017-04-28       Impact factor: 15.609

4.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.